Legend Biotech | Results Presentation Deck | 17 slides

Legend Biotech · 2024-11
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

7
coverage by narrative range · generated from this deck JSON

Slide inventory

17
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
03
front_matter
04
The slide title 'Forward-looking Statements' is unusual for a team bio slide, suggesting this may be a transition slide or a placeholder for a legal disclaimer front_matter
05
summarize
Open slide detailBeat · Interest
06
Data from CARTITUDE-4 study update presented at International Myeloma Society 2024.analyze_data
Open slide detailBeat · Surface Observation
07
The slide uses a growth curve to visualize facility ramp-ups and milestones from 1H22 to 2030.plan_implementation
08
The chart shows a stacked bar chart of quarterly sales from Q2 2022 to Q3 2024.analyze_data
Open slide detailBeat · KPI OverviewLoop · Voice Of Customer
09
The slide uses a hub-and-spoke visual layout to connect the product brand to five key strategic pillars.summarize
Open slide detailBeat · Key Messages
10
The chart is a 3D pie chart showing the split between Inpatient and Outpatient settings.quantify_opportunity
11
The slide uses a timeline-like structure to show clinical trial progression for various therapeutic assets.plan_implementation
Open slide detailBeat · Roadmap
12
analyze_data
13
The waterfall chart shows a bridge from 145 to 175, with a 30 unit increase. The R&D delta is shown as 0.analyze_data
14
summarize
Open slide detailBeat · Timeline
15
The chart highlights Carvykti's rapid growth compared to competitors like Kymriah, Yescarta, Tecartus, Breyanzi, and Abecma.analyze_data
16
summarize
17
summarize